By Mrinalika Roy (Reuters) -Advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Tuesday voted unanimously to recommend use of Novavax Inc’s COVID-19 vaccine for individuals aged 18 and above. The shot has been endorsed by the CDC’s Advisory Committee on Immunization Practices (ACIP). CDC Director Rochelle Walensky still needs to sign off on the recommendations before the vaccine can be made available in the United States. The U.S. government has secured 3.2 million Novavax vaccine doses. Novavax said in an emailed statement on Tuesday that the FDA had cleared the first lot…